Income Statement Synlogic, Inc.

Stocks

SYBX

US87166L2097

Biotechnology & Medical Research

Market Closed - OTC Markets 15:57:47 2026-09-04 EDT			5-day change	1st Jan Change
1.170 ^USD	-4.10%		-4.10%	+4.46%

08-11	Synlogic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Caldera Therapeutics, Inc. entered into an agreement and plan of merger to acquire Synlogic, Inc. for an enterprise value of approximately $500 million in a reverse merger transaction.	CI

fa2a11a.plW9UJjT_ODpLrtcV1yonUQ4ziNc3TApoUNvhyNLre0.-WCNHqrmuJGkGvluOx3NrTJ6oEYbp0VL1g0fwUARnp3DHcQ1wue01Ix0yA

Published financial data: SYNLOGIC, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	1.75M	1.18M	3.37M	8K	-
Total Revenues	1.75M	1.18M	3.37M	8K	-
Cost of Goods Sold, Total	-	-	-	-	-
Gross Profit	1.75M	1.18M	3.37M	8K	-
Selling General & Admin Expenses, Total	15.39M	16.56M	14.56M	6.63M	3.49M
R&D Expenses	47.13M	52.04M	43.97M	9.15M	43K
Other Operating Expenses, Total	62.52M	68.6M	58.53M	15.78M	3.53M
Operating Income	-60.76M	-67.42M	-55.16M	-15.78M	-3.53M
Interest Expense, Total	-2K	-2K	-1K	-	-
Interest And Investment Income	210K	1.27M	2.47M	1.42M	695K
Net Interest Expenses	208K	1.26M	2.47M	1.42M	695K
Currency Exchange Gains (Loss)	-4K	7K	-517K	-2K	-
Other Non Operating Income (Expenses)	-	-	-4.06M	16.17M	2.31M
EBT, Excl. Unusual Items	-60.56M	-66.15M	-57.27M	1.82M	-529K
Restructuring Charges	-	-	-	-25.17M	-476K
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-60.56M	-66.15M	-57.27M	-23.35M	-1M
Income Tax Expense	-	-	14K	5K	-
Earnings From Continuing Operations	-60.56M	-66.15M	-57.28M	-23.36M	-1M
Net Income to Company	-60.56M	-66.15M	-57.28M	-23.36M	-1M
Net Income - (IS)	-60.56M	-66.15M	-57.28M	-23.36M	-1M
Net Income to Common Incl Extra Items	-60.56M	-66.15M	-57.28M	-23.36M	-1M
Net Income to Common Excl. Extra Items	-60.56M	-66.15M	-57.28M	-23.36M	-1M
Per Share Items
Net EPS - Basic	-16.42	-13.83	-8.81	-1.92	-0.08
Basic EPS - Continuing Operations	-16.42	-13.83	-8.81	-1.92	-0.08
Basic Weighted Average Shares Outstanding	3.69M	4.78M	6.5M	12.2M	12.31M
Net EPS - Diluted	-16.42	-13.83	-8.81	-1.92	-0.08
Diluted EPS - Continuing Operations	-16.42	-13.83	-8.81	-1.92	-0.08
Diluted Weighted Average Shares Outstanding	3.69M	4.78M	6.5M	12.2M	12.31M
Normalized Basic EPS	-10.26	-8.65	-5.5	0.09	-0.03
Normalized Diluted EPS	-10.26	-8.65	-5.5	0.09	-0.03
Supplemental Items
EBITDA	-58.32M	-64.9M	-53.2M	-15.43M	-3.18M
EBITA	-60.76M	-67.42M	-55.16M	-15.78M	-3.53M
EBIT	-60.76M	-67.42M	-55.16M	-15.78M	-3.53M
EBITDAR	-53M	-58.68M	-46.75M	-12.76M	-
Effective Tax Rate - (Ratio)	-	-	-0.02	-0.02	-
Normalized Net Income	-37.85M	-41.34M	-35.79M	1.14M	-331K
Interest on Long-Term Debt	2K	2K	1K	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	15.39M	16.56M	14.56M	6.63M	3.49M
Research And Development Expense From Footnotes	47.13M	52.04M	43.97M	9.15M	43K
Net Rental Expense, Total	5.32M	6.22M	6.45M	2.67M	-
Imputed Operating Lease Interest Expense	3.92K	4.83K	2.74K	-	-
Imputed Operating Lease Depreciation	5.32M	6.22M	6.45M	-	-
Stock-Based Comp., R&D Exp. (Total)	1.37M	1.56M	1.02M	232K	-
Stock-Based Comp., G&A Exp. (Total)	1.99M	2.07M	1.78M	570K	117K
Total Stock-Based Compensation	3.36M	3.64M	2.81M	802K	117K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	16.44M	15.86M	23.96M	18.86M	14.67M
Short Term Investments	112M	61.77M	23.79M	-	-
Total Cash And Short Term Investments	129M	77.63M	47.75M	18.86M	14.67M
Prepaid Expenses	1.69M	1.66M	1.23M	627K	681K
Other Current Assets, Total	3.03M	495K	934K	289K	48K
Total Current Assets	133M	79.78M	49.91M	19.78M	15.4M
Gross Property Plant And Equipment	33.6M	34.82M	31.99M	-	-
Accumulated Depreciation	-10.63M	-13.14M	-14.28M	-	-
Net Property Plant And Equipment	22.98M	21.68M	17.7M	-	-
Long-term Investments	8.04M	-	-	-	-
Deferred Charges Long-Term	9.31M	8.3M	6.82M	-	-
Other Long-Term Assets, Total	1.1M	1.1M	1.11M	50K	50K
Total Assets	175M	111M	75.55M	19.83M	15.45M
Liabilities
Accounts Payable, Total	1.94M	1.78M	1.46M	164K	103K
Accrued Expenses, Total	4.4M	5.29M	3M	381K	167K
Current Portion of Leases	3.2M	4.16M	4.78M	-	-
Unearned Revenue Current, Total	531K	882K	-	-	-
Other Current Liabilities	-	-	11.16M	6.53M	3.31M
Total Current Liabilities	10.08M	12.12M	20.4M	7.08M	3.58M
Long-Term Leases	17.39M	16.13M	12.49M	-	-
Unearned Revenue Non Current	-	-	-	-	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	27.47M	28.26M	32.9M	7.08M	3.58M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	70K	71K	10K	12K	12K
Additional Paid In Capital	438M	442M	459M	457M	457M
Retained Earnings	-291M	-357M	-414M	-442M	-443M
Treasury Stock	-	-2.52M	-2.52M	-2.52M	-2.52M
Comprehensive Income and Other	-45K	-161K	6K	-	-
Total Common Equity	147M	82.61M	42.66M	12.75M	11.86M
Total Equity	147M	82.61M	42.66M	12.75M	11.86M
Total Liabilities And Equity	175M	111M	75.55M	19.83M	15.45M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.68M	4.52M	11.65M	11.7M	11.7M
ECS Total Common Shares Outstanding	4.65M	4.45M	9.19M	11.7M	11.7M
Book Value / Share	31.69	18.57	4.64	1.09	1.01
Tangible Book Value	147M	82.61M	42.66M	12.75M	11.86M
Tangible Book Value Per Share	31.69	18.57	4.64	1.09	1.01
Total Debt	20.59M	20.3M	17.28M	0	0
Net Debt	-116M	-57.33M	-30.47M	-18.86M	-14.67M
Debt Equivalent Oper. Leases	42.59M	49.77M	51.62M	21.38M	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	9.53M	10.61M	9.88M	-	-
Full Time Employees	84	72	6	1	1
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-60.56M	-66.15M	-57.28M	-23.36M	-1M
Depreciation & Amortization - CF	2.44M	2.52M	1.96M	347K	-
Depreciation & Amortization, Total	2.44M	2.52M	1.96M	347K	-
(Gain) Loss From Sale Of Asset	-	-	-11K	-1.16M	-81K
(Gain) Loss on Sale of Investments - (CF)	261K	-772K	-818K	-242K	-
Asset Writedown & Restructuring Costs	-	-	-	19.8M	-
Stock-Based Compensation (CF)	3.36M	3.64M	2.81M	3.17M	117K
Other Operating Activities, Total	2.1M	3.15M	7.9M	-18.5M	-2.31M
Change In Accounts Payable	538K	697K	-2.65M	-2.26M	-1.18M
Change in Unearned Revenues	531K	351K	-882K	-	-
Change in Other Net Operating Assets	-869K	-325K	-2.64M	-9.46M	101K
Cash from Operations	-52.2M	-56.89M	-51.61M	-31.66M	-4.36M
Capital Expenditure	-679K	-728K	-214K	-14K	-
Sale of Property, Plant, and Equipment	-	-	16K	1.33M	167K
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-52.57M	59.08M	38.97M	24.02M	-
Cash from Investing	-53.25M	58.35M	38.77M	25.34M	167K
Long-Term Debt Repaid, Total	-8K	-13K	-13K	-4K	-
Total Debt Repaid	-8K	-13K	-13K	-4K	-
Issuance of Common Stock	89.46M	491K	20.96M	176K	-
Repurchase of Common Stock	-73K	-2.52M	-	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	89.38M	-2.04M	20.94M	172K	-
Net Change in Cash	-16.07M	-577K	8.1M	-6.15M	-4.19M
Supplemental Items
Cash Interest Paid	2K	2K	1K	-	-
Cash Income Tax Paid (Refund)	-	-	14K	5K	-
Levered Free Cash Flow	-30.06M	-33.06M	-22.27M	-25.91M	-5.39M
Unlevered Free Cash Flow	-30.06M	-33.06M	-22.27M	-25.91M	-5.39M
Change In Net Working Capital	-2.79M	-3.65M	-7.66M	17.18M	3.3M
Net Debt Issued / Repaid	-8K	-13K	-13K	-4K	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-23.84	-29.51	-36.99	-20.68	-12.52
Return on Total Capital	-24.84	-31.12	-42.34	-31.4	-17.94
Return On Equity %	-46.16	-57.55	-91.46	-102.63	-8.17
Return on Common Equity	-46.16	-57.55	-91.46	-102.63	-8.17
Margin Analysis
Gross Profit Margin %	100	100	100	100	-
SG&A Margin	877.54	1.4K	431.95	82.89K	-
EBITDA Margin %	-3.33K	-5.5K	-1.58K	-193K	-
EBITA Margin %	-3.46K	-5.71K	-1.64K	-197K	-
EBIT Margin %	-3.46K	-5.71K	-1.64K	-197K	-
Income From Continuing Operations Margin %	-3.45K	-5.61K	-1.7K	-292K	-
Net Income Margin %	-3.45K	-5.61K	-1.7K	-292K	-
Net Avail. For Common Margin %	-3.45K	-5.61K	-1.7K	-292K	-
Normalized Net Income Margin	-2.16K	-3.5K	-1.06K	14.21K	-
Levered Free Cash Flow Margin	-1.71K	-2.8K	-660.67	-324K	-
Unlevered Free Cash Flow Margin	-1.71K	-2.8K	-660.65	-324K	-
Asset Turnover
Asset Turnover	0.01	0.01	0.04	0	-
Fixed Assets Turnover	0.07	0.05	0.17	-	-
Short Term Liquidity
Current Ratio	13.23	6.58	2.45	2.8	4.3
Quick Ratio	12.76	6.4	2.34	2.67	4.09
Operating Cash Flow to Current Liabilities	-5.18	-4.69	-2.53	-4.47	-1.22
Average Days Payable Outstanding	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	13.98	24.57	40.5	-	-
Total Debt / Total Capital	12.27	19.72	28.83	-	-
LT Debt/Equity	11.81	19.53	29.28	-	-
Long-Term Debt / Total Capital	10.36	15.68	20.84	-	-
Total Liabilities / Total Assets	15.72	25.49	43.54	35.69	23.2
EBIT / Interest Expense	-30.38K	-33.71K	-55.16K	-	-
EBITDA / Interest Expense	-26.5K	-29.34K	-46.75K	-	-
(EBITDA - Capex) / Interest Expense	-26.84K	-29.7K	-46.96K	-	-
Total Debt / EBITDA	-0.39	-0.35	-0.37	-	-
Net Debt / EBITDA	2.19	0.98	0.65	1.22	4.61
Total Debt / (EBITDA - Capex)	-0.38	-0.34	-0.37	-	-
Net Debt / (EBITDA - Capex)	2.16	0.97	0.65	1.22	4.61
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	221.83	-32.73	185.68	-99.76	-
Gross Profit, 1 Yr. Growth %	221.83	-32.73	185.68	-99.76	-
EBITDA, 1 Yr. Growth %	0.85	11.28	-18.02	-71	-79.36
EBITA, 1 Yr. Growth %	0.49	10.95	-18.18	-71.4	-77.61
EBIT, 1 Yr. Growth %	0.49	10.95	-18.18	-71.4	-77.61
Earnings From Cont. Operations, 1 Yr. Growth %	2.35	9.22	-13.4	-61.88	-95.7
Net Income, 1 Yr. Growth %	2.35	9.22	-13.4	-61.88	-95.7
Normalized Net Income, 1 Yr. Growth %	2.35	9.22	-13.42	-102.97	-129.08
Diluted EPS Before Extra, 1 Yr. Growth %	-33.71	-15.74	-36.32	-79.68	-95.74
Net Property, Plant and Equip., 1 Yr. Growth %	-12.64	-5.65	-18.33	-	-
Total Assets, 1 Yr. Growth %	21.48	-36.55	-31.85	-73.76	-22.09
Tangible Book Value, 1 Yr. Growth %	27.91	-43.9	-48.37	-61.09	-6.96
Common Equity, 1 Yr. Growth %	27.91	-43.9	-48.37	-61.09	-6.96
Cash From Operations, 1 Yr. Growth %	31.97	8.98	-9.27	-38.66	-86.23
Capital Expenditures, 1 Yr. Growth %	71.9	7.22	-70.6	-93.46	-
Levered Free Cash Flow, 1 Yr. Growth %	19.01	9.96	-32.63	109.16	-77.09
Unlevered Free Cash Flow, 1 Yr. Growth %	19.03	9.96	-32.63	109.17	-77.09
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.19	47.14	38.63	-91.77	-
Gross Profit, 2 Yr. CAGR %	-11.19	47.14	38.63	-91.77	-
EBITDA, 2 Yr. CAGR %	6.2	5.94	-4.49	-51.24	-75.53
EBITA, 2 Yr. CAGR %	5.68	5.59	-4.72	-51.62	-74.7
EBIT, 2 Yr. CAGR %	5.68	5.59	-4.72	-51.62	-74.7
Earnings From Cont. Operations, 2 Yr. CAGR %	8.57	5.73	-2.74	-40.57	-87.19
Net Income, 2 Yr. CAGR %	8.57	5.73	-2.74	-40.57	-87.19
Normalized Net Income, 2 Yr. CAGR %	8.57	5.73	-2.76	-83.42	-90.71
Diluted EPS Before Extra, 2 Yr. CAGR %	-19.67	-25.27	-26.75	-62.79	-90.69
Net Property, Plant and Equip., 2 Yr. CAGR %	-12.9	-9.21	-12.22	-	-
Total Assets, 2 Yr. CAGR %	-3.74	-12.21	-34.25	-57.71	-54.78
Tangible Book Value, 2 Yr. CAGR %	-3.12	-15.29	-46.18	-60.71	-39.83
Common Equity, 2 Yr. CAGR %	-3.12	-15.29	-46.18	-60.71	-39.83
Cash From Operations, 2 Yr. CAGR %	-16.83	19.93	-0.56	-25.4	-70.94
Capital Expenditures, 2 Yr. CAGR %	-26.33	35.76	-43.86	-86.13	-
Levered Free Cash Flow, 2 Yr. CAGR %	-15.31	14.4	-13.93	-11.47	-34.01
Unlevered Free Cash Flow, 2 Yr. CAGR %	-15.3	14.4	-13.93	-11.47	-34.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-11.38	-19.04	83.56	-83.42	-
Gross Profit, 3 Yr. CAGR %	-47.86	-19.04	83.56	-83.42	-
EBITDA, 3 Yr. CAGR %	6.12	7.87	-2.74	-35.8	-63.39
EBITA, 3 Yr. CAGR %	5.85	7.41	-3.01	-36.2	-62.58
EBIT, 3 Yr. CAGR %	5.85	7.41	-3.01	-36.2	-62.58
Earnings From Cont. Operations, 3 Yr. CAGR %	7.73	8.79	-1.08	-27.21	-75.23
Net Income, 3 Yr. CAGR %	7.73	8.79	-1.08	-27.21	-75.23
Normalized Net Income, 3 Yr. CAGR %	7.73	8.79	-1.08	-68.92	-80
Diluted EPS Before Extra, 3 Yr. CAGR %	-18.58	-18.38	-29.15	-51.14	-81.93
Net Property, Plant and Equip., 3 Yr. CAGR %	15.68	-10.54	-12.36	-	-
Total Assets, 3 Yr. CAGR %	7.58	-16.23	-19.32	-51.59	-48.16
Tangible Book Value, 3 Yr. CAGR %	5.87	-19.25	-28.18	-55.76	-47.63
Common Equity, 3 Yr. CAGR %	5.87	-19.25	-28.18	-55.76	-47.63
Cash From Operations, 3 Yr. CAGR %	7.12	-8.99	9.28	-15.35	-57.53
Capital Expenditures, 3 Yr. CAGR %	-50.66	-16.51	-18.48	-72.58	-
Levered Free Cash Flow, 3 Yr. CAGR %	-1.58	-7.61	-4.11	-4.84	-45.35
Unlevered Free Cash Flow, 3 Yr. CAGR %	-1.55	-7.6	-4.11	-4.84	-45.35
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	31.62	-13.55	5.99	-67.55	-
Gross Profit, 5 Yr. CAGR %	31.62	-13.55	-22.9	-67.55	-
EBITDA, 5 Yr. CAGR %	23.53	11	1.74	-21.48	-44
EBITA, 5 Yr. CAGR %	23.72	10.55	1.49	-21.93	-43.34
EBIT, 5 Yr. CAGR %	23.72	10.55	1.49	-21.93	-43.34
Earnings From Cont. Operations, 5 Yr. CAGR %	23.65	10.38	3.41	-14.58	-55.74
Net Income, 5 Yr. CAGR %	23.65	10.38	3.41	-14.58	-55.74
Normalized Net Income, 5 Yr. CAGR %	23.65	10.38	3.41	-48.74	-61.07
Diluted EPS Before Extra, 5 Yr. CAGR %	-39.32	-31.25	-21.95	-40.39	-68.12
Net Property, Plant and Equip., 5 Yr. CAGR %	45.66	17.25	3.59	-	-
Total Assets, 5 Yr. CAGR %	54.21	2.15	-11.65	-36.27	-36
Tangible Book Value, 5 Yr. CAGR %	36.87	-0.58	-19.23	-39.47	-36.53
Common Equity, 5 Yr. CAGR %	36.87	-0.58	-19.23	-39.47	-36.53
Cash From Operations, 5 Yr. CAGR %	20.66	12.87	3.98	-15.95	-35.67
Capital Expenditures, 5 Yr. CAGR %	-18.09	-22.34	-48.05	-59.28	-
Levered Free Cash Flow, 5 Yr. CAGR %	17.19	12.15	-6.72	-9.17	-26.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	17.19	12.19	-6.7	-9.17	-26.56